Bio-Rad Laboratories SG&A Expenses 2010-2023 | BIO
- Bio-Rad Laboratories sg&a expenses for the quarter ending December 31, 2023 were $0.207B, a 2.39% decline year-over-year.
- Bio-Rad Laboratories sg&a expenses for the twelve months ending December 31, 2023 were $0.842B, a 1.68% increase year-over-year.
- Bio-Rad Laboratories annual sg&a expenses for 2023 were $0.842B, a 1.68% increase from 2022.
- Bio-Rad Laboratories annual sg&a expenses for 2022 were $0.828B, a 5.62% decline from 2021.
- Bio-Rad Laboratories annual sg&a expenses for 2021 were $0.877B, a 9.81% increase from 2020.
Bio-Rad Laboratories Annual SG&A Expenses (Millions of US $) |
|
---|---|
2023 | $842 |
2022 | $828 |
2021 | $877 |
2020 | $799 |
2019 | $825 |
2018 | $835 |
2017 | $807 |
2016 | $815 |
2015 | $762 |
2014 | $808 |
2013 | $798 |
2012 | $682 |
2011 | $696 |
2010 | $635 |
2009 | $601 |
Bio-Rad Laboratories Quarterly SG&A Expenses (Millions of US $) |
|
---|---|
2023-12-31 | $207 |
2023-09-30 | $201 |
2023-06-30 | $208 |
2023-03-31 | $226 |
2022-12-31 | $212 |
2022-09-30 | $211 |
2022-06-30 | $208 |
2022-03-31 | $197 |
2021-12-31 | $222 |
2021-09-30 | $216 |
2021-06-30 | $213 |
2021-03-31 | $226 |
2020-12-31 | $218 |
2020-09-30 | $198 |
2020-06-30 | $189 |
2020-03-31 | $194 |
2019-12-31 | $214 |
2019-09-30 | $202 |
2019-06-30 | $201 |
2019-03-31 | $208 |
2018-12-31 | $214 |
2018-09-30 | $201 |
2018-06-30 | $210 |
2018-03-31 | $209 |
2017-12-31 | $202 |
2017-09-30 | $198 |
2017-06-30 | $212 |
2017-03-31 | $194 |
2016-12-31 | $218 |
2016-09-30 | $201 |
2016-06-30 | $206 |
2016-03-31 | $190 |
2015-12-31 | $193 |
2015-09-30 | $187 |
2015-06-30 | $193 |
2015-03-31 | $189 |
2014-12-31 | $208 |
2014-09-30 | $203 |
2014-06-30 | $196 |
2014-03-31 | $202 |
2013-12-31 | $215 |
2013-09-30 | $202 |
2013-06-30 | $195 |
2013-03-31 | $186 |
2012-12-31 | $188 |
2012-09-30 | $160 |
2012-06-30 | $162 |
2012-03-31 | $171 |
2011-12-31 | $175 |
2011-09-30 | $177 |
2011-06-30 | $177 |
2011-03-31 | $168 |
2010-12-31 | $177 |
2010-09-30 | $149 |
2010-06-30 | $156 |
2010-03-31 | $154 |
2009-12-31 | $164 |
2009-09-30 | $154 |
2009-06-30 | $144 |
2009-03-31 | $140 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $8.140B | $2.671B |
Bio-Rad Laboratories is a manufacturer and global supplier of clinical diagnostics and life science research products in the healthcare, analytical chemistry life science research and other markets. It offers a wide portfolio of products and systems which allow the separation of complex chemical and biological materials and discovery, analysis and purification of their components. Bio-Rad has extensive and direct distribution channels outside the United States through subsidiaries which focus on sales, customer service and product distribution. The company operates through two reportable segments - Life Science segment which designs, manufactures, markets and services reagents, apparatus and instruments utilized for biological research. Clinical Diagnostics - This business markets and distributes products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians office laboratories, transfusion laboratories as well as insurance and forensic testing laboratories. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $182.261B | 23.87 |
Stryker (SYK) | United States | $123.641B | 29.61 |
Medtronic (MDT) | Ireland | $110.900B | 15.70 |
Boston Scientific (BSX) | United States | $106.819B | 34.02 |
EssilorLuxottica (ESLOY) | France | $100.527B | 0.00 |
Lonza Group Ag (LZAGY) | Switzerland | $42.760B | 0.00 |
Haleon (HLN) | United Kingdom | $37.671B | 27.50 |
ResMed (RMD) | United States | $32.010B | 30.05 |
Terumo (TRUMY) | Japan | $25.312B | 35.75 |
Koninklijke Philips (PHG) | Netherlands | $25.036B | 19.40 |
Zimmer Biomet Holdings (ZBH) | United States | $24.603B | 15.72 |
Baxter (BAX) | United States | $18.054B | 12.84 |
Insulet (PODD) | United States | $11.278B | 50.01 |
Smith & Nephew SNATS (SNN) | United Kingdom | $10.977B | 0.00 |
Demant (WILYY) | Denmark | $10.234B | 0.00 |
BellRing Brands (BRBR) | United States | $7.808B | 36.57 |
Lantheus Holdings (LNTH) | United States | $5.398B | 13.45 |
Haemonetics (HAE) | United States | $4.886B | 24.17 |
GN Store Nord (GNNDY) | Denmark | $4.400B | 24.71 |
Perrigo (PRGO) | Ireland | $4.199B | 12.73 |
Prestige Consumer Healthcare (PBH) | United States | $3.500B | 16.55 |
Envista Holdings (NVST) | United States | $3.241B | 13.38 |
QuidelOrtho (QDEL) | United States | $2.820B | 15.65 |
Neogen (NEOG) | United States | $2.781B | 26.75 |
Green Thumb Industries (GTBIF) | United States | $2.736B | 54.19 |
TG Therapeutics (TGTX) | United States | $2.677B | 75.30 |
Maravai LifeSciences Holdings (MRVI) | United States | $2.647B | 0.00 |
ICU Medical (ICUI) | United States | $2.641B | 23.31 |
Agios Pharmaceuticals (AGIO) | United States | $1.904B | 0.00 |
LeMaitre Vascular (LMAT) | United States | $1.711B | 50.14 |
Verano Holdings (VRNOF) | United States | $1.693B | 0.00 |
InMode (INMD) | Israel | $1.553B | 8.25 |
Warby Parker (WRBY) | United States | $1.536B | 0.00 |
Owens & Minor (OMI) | United States | $1.431B | 12.47 |
AdaptHealth (AHCO) | United States | $1.263B | 9.41 |
National Vision Holdings (EYE) | United States | $1.174B | 37.35 |
AtriCure (ATRC) | United States | $1.069B | 0.00 |
BioLife Solutions (BLFS) | United States | $0.951B | 0.00 |
Canopy Growth (CGC) | Canada | $0.950B | 0.00 |
Evolus (EOLS) | United States | $0.790B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.734B | 15.61 |
Cresco Labs (CRLBF) | United States | $0.695B | 0.00 |
Quanterix (QTRX) | United States | $0.645B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.634B | 14.91 |
PetIQ (PETQ) | United States | $0.572B | 18.69 |
Valneva SE (VALN) | France | $0.530B | 0.00 |
Jin Medical (ZJYL) | China | $0.515B | 0.00 |
TerrAscend (TSNDF) | Canada | $0.498B | 0.00 |
Surmodics (SRDX) | United States | $0.463B | 28.97 |
ZimVie (ZIMV) | United States | $0.459B | 39.12 |
Biote (BTMD) | United States | $0.448B | 8.59 |
OraSure Technologies (OSUR) | United States | $0.382B | 12.29 |
Cerus (CERS) | United States | $0.370B | 0.00 |
Aurora Cannabis (ACB) | Canada | $0.364B | 0.00 |
Zynex (ZYXI) | United States | $0.339B | 46.44 |
MacroGenics (MGNX) | United States | $0.274B | 0.00 |
TriSalus Life Sciences (TLSI) | United States | $0.274B | 0.00 |
Viemed Healthcare (VMD) | United States | $0.274B | 27.11 |
Sanara MedTech (SMTI) | United States | $0.252B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.242B | 15.22 |
Omeros (OMER) | United States | $0.217B | 0.00 |
Veru (VERU) | United States | $0.195B | 0.00 |
Organigram Holdings (OGI) | Canada | $0.190B | 0.00 |
Ayr Wellness (AYRWF) | United States | $0.187B | 0.00 |
High Tide (HITI) | Canada | $0.178B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.172B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.171B | 0.00 |
Eagleford Energy (GRUSF) | United States | $0.154B | 74.00 |
InterCure (INCR) | Israel | $0.141B | 23.77 |
FitLife Brands (FTLF) | United States | $0.140B | 22.57 |
Jushi Holdings (JUSHF) | United States | $0.130B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.110B | 0.00 |
Fonar (FONR) | United States | $0.103B | 8.83 |
MariMed (MRMD) | United States | $0.099B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.098B | 0.00 |
Chimerix (CMRX) | United States | $0.094B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.093B | 0.00 |
Brainsway (BWAY) | Israel | $0.092B | 0.00 |
Safety Shot (SHOT) | United States | $0.073B | 0.00 |
Zevia PBC (ZVIA) | United States | $0.067B | 0.00 |
Eagle Pharmaceuticals (EGRX) | United States | $0.058B | 3.81 |
Rockwell Medical (RMTI) | United States | $0.050B | 0.00 |
Apyx Medical (APYX) | United States | $0.050B | 0.00 |
Cytosorbents (CTSO) | United States | $0.045B | 0.00 |
United-Guardian (UG) | United States | $0.042B | 15.25 |
ImmuCell (ICCC) | United States | $0.041B | 0.00 |
Modular Medical (MODD) | United States | $0.040B | 0.00 |
Bright Green (BGXX) | United States | $0.040B | 0.00 |
Exagen (XGN) | United States | $0.028B | 0.00 |
Nephros (NEPH) | United States | $0.022B | 0.00 |
Agape ATP (ATPC) | $0.018B | 0.00 | |
Meihua Medical Technologies (MHUA) | China | $0.018B | 0.00 |
Flora Growth (FLGC) | United States | $0.017B | 0.00 |
FSD PHARMA (HUGE) | Canada | $0.015B | 0.00 |
GlucoTrack (GCTK) | United States | $0.014B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
GUARDION HEALTH (GHSI) | United States | $0.011B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.009B | 0.00 |
NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
Leafly Holdings (LFLY) | United States | $0.004B | 0.00 |
Senestech (SNES) | United States | $0.004B | 0.00 |
Sharps Technology (STSS) | United States | $0.004B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.002B | 0.00 |
Lucy Scientific Discovery (LSDI) | Canada | $0.001B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
Smart For Life (SMFL) | United States | $0.000B | 0.00 |
Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
SNDL (SNDL) | Canada | $0.000B | 0.00 |